-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SU7Mk9Wsyh/aWQIqZuDdVNa1qhuI/y1fv01pTf+OCpakE80xHTB24dghLo5zTbdO cVaEDcOwE5urs08KdanAqg== 0001035704-01-000090.txt : 20010223 0001035704-01-000090.hdr.sgml : 20010223 ACCESSION NUMBER: 0001035704-01-000090 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010214 GROUP MEMBERS: BOULDER VENTURES II (ANNEX), L.P. GROUP MEMBERS: BOULDER VENTURES II LP GROUP MEMBERS: BV PARTNERS II, LLC GROUP MEMBERS: JOSH E. FIDLER GROUP MEMBERS: KYLE LEFKOFF GROUP MEMBERS: LAWRENCE M. MACKS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-60323 FILM NUMBER: 1546052 BUSINESS ADDRESS: STREET 1: 1885 33RD ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 1885 33RD STREET CITY: BOULDER STATE: CO ZIP: 80301 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOULDER VENTURES II LP CENTRAL INDEX KEY: 0001039678 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 841403906 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1941 PEARL STREET STREET 2: # 300 CITY: BOULDER STATE: CO ZIP: 80302 BUSINESS PHONE: 3034446950 MAIL ADDRESS: STREET 1: 1941 PEARL STREET STREET 2: #300 CITY: BOULDER STATE: CO ZIP: 80302 SC 13G 1 d84286sc13g.txt SCHEDULE 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13D-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(b). (AMENDMENT NO. _________)* ARRAY BIOPHARMA INC. -------------------- (Name of Issuer) COMMON STOCK ------------------------------ (Title of Class of Securities) 04269X-10-5 -------------- (CUSIP Number) (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 2 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BOULDER VENTURES II, L.P. 84-1403906 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 2 cof 12 3 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 3 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BV PARTNERS II, LLC 84-1509379 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) LLC - -------------------------------------------------------------------------------- Page 3 cof 12 4 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 4 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BOULDER VENTURES II (ANNEX), L.P. 84-1450959 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 4 cof 12 5 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 5 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) KYLE LEFKOFF - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 5 cof 12 6 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 6 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) JOSH E. FIDLER - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 6 cof 12 7 SCHEDULE 13G - --------------------- ------------------ CUSIP No. 04269X-10-5 Page 7 of 12 Pages - --------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) LAWRENCE M. MACKS - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,770,406 OWNED BY --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------- WITH: 8 SHARED DISPOSITIVE POWER 1,770,406 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,770,406 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.7% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -------------------------------------------------------------------------------- Page 7 cof 12 8 ITEM 1(a) NAME OF ISSUER: This Schedule 13G relates to Array BioPharma Inc, a Delaware corporation (the "Company"). ITEM 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: The Company's principal executive offices are located at 1885 33rd Street, Boulder, Colorado 80301. ITEM 2(a) NAME OF PERSON FILING: This Schedule 13G relates to each of the following persons: o Boulder Ventures II, L.P., a limited partnership ("BV II") o BV Partners II, LLC, a limited liability company ("BV Partners") o Boulder Ventures II (Annex), L.P., a limited partnership ("BV Annex") o Kyle Lefkoff, a member and manager of BV Partners o Josh E. Fidler, a member and manager of BV Partners o Lawrence M. Macks, a member and manager of BV Partners ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The business address of each reporting person is 1941 Pearl Street, #300, Boulder, CO 80302. ITEM 2(c) CITIZENSHIP: BV II is a limited partnership organized under the laws of the State of Delaware. BV Partners is a limited liability company organized under the laws of the State of Delaware. BV Annex is a limited partnership organized under the laws of the State of Delaware. Messrs. Lefkoff, Fidler and Macks are United States citizens. ITEM 2(d) TITLE OF CLASS OF SECURITIES: This Schedule 13G relates to the Company's common stock, par value $0.001 per share (the "Common Stock"). ITEM 2(e) CUSIP NUMBER: The CUSIP Number for the Company's Common Stock is 04269X-10-5. ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(b), OR 13D-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ] Investment company as defined in Section 8 of the Investment Company Act. Page 8 of 12 9 (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c) (14) of the Investment Company Act. (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). ITEM 4 OWNERSHIP: The following describes the ownership of Common Stock by BV II, BV Partners, BV Annex and Messrs. Lefkoff, Fidler and Macks as of December 31, 2000: (a) Amount beneficially owned: 1,770,406 (b) Percent of class: 7.7% (1) (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 0 (ii) Shared power to vote or direct the vote: 1,770,406 (2) (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1,770,406 (2) (1) Based on 22,956,188 shares of Common Stock outstanding as of December 31, 2000. (2) Represents 1,540,253 shares held directly by BV II and 230,153 shares held directly by BV Annex, an affiliate of BV II. The general partner of BV II and of BV Annex is BV Partners. Messrs. Lefkoff, Fidler and Macks are each members and managers of BV Partners and share voting and dispositive power for these shares. Messrs. Lefkoff, Fidler and Macks each disclaims beneficial ownership of these shares except to the extent of their respective pecuniary interest in such shares. ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF CLASS: Not applicable. ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. Page 9 of 12 10 ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9 NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10 CERTIFICATION: Not applicable. Page 10 of 12 11 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Dated: February 14, 2001 BOULDER VENTURES II, L.P. By: BV PARTNERS II, LLC By: /s/ Kyle Lefkoff ------------------------------- Kyle Lefkoff, Member and Manager BOULDER VENTURES II (ANNEX), L.P. By: BV PARTNERS II, LLC By: /s/ Kyle Lefkoff ------------------------------- Kyle Lefkoff, Member and Manager BV PARTNERS II, LLC By: /s/ Kyle Lefkoff ------------------------------- Kyle Lefkoff, Member and Manager /s/ Kyle Lefkoff ----------------------------------- Kyle Lefkoff /s/ Josh E. Fidler ----------------------------------- Josh E. Fidler /s/ Lawrence M. Macks ----------------------------------- Lawrence M. Macks Page 11 of 12 12 EXHIBIT A AGREEMENT REGARDING JOINT FILING Boulder Ventures II, L.P., Boulder Ventures II (Annex), L.P., BV Partners, LLC, Kyle Lefkoff, Josh E. Fidler and Lawrence M. Macks hereby agree to file this schedule jointly pursuant to Rule 13d-1(k)(1). Date: February 14, 2001 BOULDER VENTURES II, L.P. By: BV PARTNERS II, LLC By: /s/ Kyle Lefkoff -------------------------------- Kyle Lefkoff, Member and Manager BOULDER VENTURES II (ANNEX), L.P. By: BV PARTNERS II, LLC By: /s/ Kyle Lefkoff -------------------------------- Kyle Lefkoff, Member and Manager BV PARTNERS II, LLC By: /s/ Kyle Lefkoff -------------------------------- Kyle Lefkoff, Member and Manager /s/ Kyle Lefkoff ----------------------------------- Kyle Lefkoff /s/ Josh E. Fidler ----------------------------------- Josh E. Fidler /s/ Lawrence M. Macks ----------------------------------- Lawrence M. Macks Page 12 of 12 -----END PRIVACY-ENHANCED MESSAGE-----